CD44 and breast carcinoma: To address this, we isolated BCSCs from the ER+ breast cancer cell line MCF7 using two methods: flow cytometry gating on ESA+CD24low/CD44+ cells [29, 30] and functional isolation by anoikis-resistance (AR) which is dependent upon survival in anchorage-independent conditions [31].